tafamidis meglumine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for tafamidis meglumine, covering 2024-03-12 to 2024-03-12. Get the full timeline:
Most recent: Clinical Trial Update: The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients [Phase 4]